Mervenur Demir

Mervenur Demir

Auto-generated profile, based on publicly available information

Mervenur Demir

Microbiology and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, Ankara, 06100, Turkey, hacettepe.edu.tr

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
MDMervenur Demir
Mervenur Demir
GHGulsen Hazirolan
Gulsen Hazirolan
Sepsis is a life-threatening infection with a mortality rate above 25%. Rapid identification of the microorganisms that cause bloodstream infections is important for choosing targeted and timely antimicrobial treatment. The implementation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (...)

9 March 2022 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
MÇMervenur Demir Çuha
Mervenur Demir Çuha
AÖAdem Özdemir
Adem Özdemir
KEKübra Evren
Kübra Evren
BCBariş Can
Bariş Can
ZDZahide Doyuk
Zahide Doyuk
BŞBurçin Şener
Burçin Şener
Background: Automated chemiluminescent microparticle immunoassays (CMIAs) are the most common first step at high-volume laboratories for syphilis screening. If the initial screening test is reactive, 1 more treponemal test is required, resulting in increased cost. In this multicenter study, we aimed to determine the correlation between the CMIA signal-to-cutoff ratio (S/Co) and the confirmatory tests to reduce unnecessary confirmatory testing. Methods: Eight hospitals from 5 provinces participated in this study. All laboratories used Architect Syphilis TP CMIA (Abbott Diagnostics, Abbott Park, IL) for initial screening. Treponema pallidum hemagglutination (TPHA), rapid plasma reagin (RPR), and fluorescent treponemal antibody absorption (FTA-ABS) were used as confirmatory tests according to the reverse or European Centre for Disease Prevention and Control algorithms. A receiver operating characteristic analysis was used to determine the optimal S/Co ratio to predict the confirmation results. Results: We evaluated 129,346 serum samples screened by CMIA between January 2018 and December 2020. A total of 2468 samples were reactive; 2247 (91%) of them were confirmed to be positive and 221 (9%) were negative. Of the 2468 reactive specimens, 1747 (70.8%) had an S/Co ratio ≥10.4. When the S/Co ratios were ≥7.2 and ≥10.4, the specificity values were determined to be 95% and 100%, respectively. In a subgroup of 75 CMIA-positive patients, FTA-ABS was performed and 62 were positive. Among these FTA-ABS–positive patients, 24 had an S/Co ratio <10.4, and negative TPHA and RPR. Conclusions: We propose a potentially cost-effective reverse screening algorithm with a treponemal CMIA S/Co ratio ≥10.4, obviating the need for secondary treponemal testing in about 71% of the screening-reactive samples. This would substantially reduce the confirmatory testing volume and laboratory expenses. However, in high-risk group patients with CMIA positive results, S/Co ratio <10.4, and negative TPHA and RPR, FTA-ABS may be used for confirmation.


19 April 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
AÖAdem Özdemir
Adem Özdemir
MÇMervenur Demir Çuha
Mervenur Demir Çuha
GDGülçin Telli Dizman
Gülçin Telli Dizman
AAAlpaslan Alp
Alpaslan Alp
GMGökhan Metan
Gökhan Metan
BŞBurçin Şener
Burçin Şener
COVID-19 infection caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) continues to affect people as a global threat, and the number of cases is increasing every day. Healthcare workers who face potential COVID-19 exposure are at high risk of SARS-CoV-2 transmission. Estimating the prevalence of infection among healthcare professionals, determining the related risk factors and applying effective infection control measures are essential for the continuity of the health system. The aim of this study was to investigate the seroprevalence of SARS-CoV-2 among healthcare workers in our hospital who have participated extensively in the monitoring of COVID-19 patients. In the study, the anti-SARS-CoV-2 IgG antibody test results of 774 healthcare workers between March 24, 2020, and September 10, 2020 were analyzed retrospectively. Age, sex, profession, and the status of being diagnosed with COVID-19 before the antibody test were determined for the healthcare workers in the study. When the anti-SARS-CoV-2 IgG antibody results were evaluated, it was determined that 57 healthcare workers were positive, 708 healthcare workers were negative, and 9 healthcare workers were borderline. The seroprevalence among the workers of our hospital was found to be 7.4%. The antibody positivity rate was 75.6% in individuals diagnosed with COVID-19 by SARS-CoV-2 PCR (polymerase chain reaction) and/or thoracic computed tomography and it was found to be 3.5% in individuals without the diagnosis. The semi-quantitative antibody index values of the healthcare workers who were seropositive and diagnosed with COVID-19 before the test (n= 31) and those who did not (n= 26) were statistically compared and a significant difference was found between the two groups (p< 0.01). In our study, the highest seropositivity was observed among residents (12.3%) and among nurses (11.1%), respectively. When the seropositivity rates of the residents and the nurses were compared with other occupational groups, the differences were found to be statistically significant (p= 0.04, p= 0.04, respectively). In conclusion, the seroprevalence of SARS-CoV-2 was determined as 7.4% among healthcare workers in a tertiary hospital with high patient admissions during the COVID-19 pandemic. Considering that SARS-CoV-2 seroprevalence was announced as 0.81% in the press release made by the Ministry of Health of Turkey in July 2020, it is seen that the rate of seroprevalence among health care workers is significantly larger than the community. Determination of the seroprevalence in the general population and large-scale studies are needed for risk assessment in healthcare professionals.

28 June 2024 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
MDMervenur Demir
Mervenur Demir
GTGülçin Telli-Dizman
Gülçin Telli-Dizman
GHGulsen Hazirolan
Gulsen Hazirolan
ÖUÖmrüm Uzun
Ömrüm Uzun
GMGökhan Metan
Gökhan Metan
The global increase in the rate of multi-drug resistant (MDR) bacterial infections in recent years is an important public health problem that limits the therapeutic options. The issue becomes particularly critical in cases of bloodstream infections (BSI) in which delay is associated with high mortality rates. Bacteria grown in blood cultures (BC) must be subcultured on the solid media (...)

1 August 2021 in Anaerobe
Verified
Journal Article
Closed access
MÇMervenur Demir Çuha
Mervenur Demir Çuha
AEAhmet Görkem Er
Ahmet Görkem Er
BDBekir Mert Durukan
Bekir Mert Durukan
AKAlper Karagöz
Alper Karagöz
GHGülşen Hazırolan
Gülşen Hazırolan
SÜSerhat Ünal
Serhat Ünal